| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The changing world of cancer drug development: the regulatory bodies' perspective. | Chin Clin Oncol | 2014 | 0.75 |
| 2 | European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer. | ESMO Open | 2017 | 0.75 |